-
1
-
-
0036467228
-
A randomized, double blind, placebo controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy
-
U.S. Xyrem Multicenter Study Group
-
U.S. Xyrem Multicenter Study Group. A randomized, double blind, placebo controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep 2002;25:42-9.
-
(2002)
Sleep
, vol.25
, pp. 42-49
-
-
-
2
-
-
0038178414
-
A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy
-
U.S. Xyrem Multicenter Study Group
-
U.S. Xyrem Multicenter Study Group. A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy. Sleep 2003;26:31-5.
-
(2003)
Sleep
, vol.26
, pp. 31-35
-
-
-
3
-
-
12144291325
-
Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy
-
U.S. Xyrem Multicenter Study Group
-
U.S. Xyrem Multicenter Study Group. Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy. Sleep Med 2004;5:119-123.
-
(2004)
Sleep Med
, vol.5
, pp. 119-123
-
-
-
4
-
-
85066728475
-
A double-blind, placebo-controlled, study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy
-
Xyrem International Study Group
-
Xyrem International Study Group. A double-blind, placebo-controlled, study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy. J Clin Sleep Med 2005; 1:289-95.
-
(2005)
J Clin Sleep Med
, vol.1
, pp. 289-295
-
-
-
5
-
-
24344500187
-
Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: A double-blind, placebo-controlled study in 228 patients
-
Xyrem International Study Group
-
Xyrem International Study Group. Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients. Sleep Med 2005;6:415-21.
-
(2005)
Sleep Med
, vol.6
, pp. 415-421
-
-
-
6
-
-
0034967934
-
Narcolepsy: Clinical features, new pathophysiologic insights, and future perspectives
-
Overeem S, Mignot E, van Dijk JG, Lammers GJ. Narcolepsy: Clinical features, new pathophysiologic insights, and future perspectives. J Clin Neurophysiol 2001;18:78-105. (Pubitemid 32549906)
-
(2001)
Journal of Clinical Neurophysiology
, vol.18
, Issue.2
, pp. 78-105
-
-
Overeem, S.1
Mignot, E.2
GertvanDijk, J.3
Lammers, G.J.4
-
8
-
-
0018889118
-
Effects of nocturnal gamma-hydroxybutyrate on sleep/waking patterns in narcolepsy-cataplexy
-
Broughton R, Mamelak M. Effects of nocturnal gamma-hydroxybutyrate on sleep waking patterns in narcolepsy-cataplexy. Can J Neurol Sci 1980;7:23-30. (Pubitemid 10138870)
-
(1980)
Canadian Journal of Neurological Sciences
, vol.7
, Issue.1
, pp. 23-31
-
-
Broughton, R.1
Mamelak, M.2
-
9
-
-
0025609959
-
The effects of γ-hydroxybutyrate on the sleep of narcolepsy patients: A double blind study
-
Scrima L, Hartman PG, Johnson FH, Thomas EE, Hiller FC. The effects of γ-hydroxybutyrate on the sleep of narcolepsy patients: A double blind study. Sleep 1990;13:479-90.
-
(1990)
Sleep
, vol.13
, pp. 479-490
-
-
Scrima, L.1
Hartman, P.G.2
Johnson, F.H.3
Thomas, E.E.4
Hiller, F.C.5
-
10
-
-
0027401745
-
Gamma-hydroxybutyrate and narcolepsy: A double blind placebo controlled study
-
Lammers GJ, Arends J, Declerck AC, Ferrari MN, Schouwink G, Troost, J. Gamma-hydroxybutyrate and narcolepsy: a double blind placebo controlled study. Sleep 1993;16:216-20.
-
(1993)
Sleep
, vol.16
, pp. 216-220
-
-
Lammers, G.J.1
Arends, J.2
Declerck, A.C.3
Ferrari, M.N.4
Schouwink, G.5
Troost, J.6
-
11
-
-
16644370367
-
A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy
-
Mamelak M, Black J, Montplaisir J, Ristanovic R. A dose response study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy. Sleep 2004;27:1327-34. (Pubitemid 44138899)
-
(2004)
Sleep
, vol.27
, Issue.7
, pp. 1327-1334
-
-
Mamelak, M.1
Black, J.2
Montplaisir, J.3
Ristanovic, R.4
-
12
-
-
33749256806
-
A randomized trial evaluating the effectiveness of sodium oxybate therapy on quality of life in narcolepsy
-
Weaver TE, Cuellar N. A randomized trial evaluating the effectiveness of sodium oxybate therapy on quality of life in narcolepsy. Sleep 2006;29:1189-94. (Pubitemid 44484812)
-
(2006)
Sleep
, vol.29
, Issue.9
, pp. 1189-1194
-
-
Weaver, T.E.1
Cuellar, N.2
-
15
-
-
0018417867
-
The treatment of narcolepsy-cataplexy with nocturnal gamma- hydroxybutyrate
-
Broughton R, Mamelak M. The treatment of narcolepsy-cataplexy with nocturnal gamma-hydroxybutyrate. Can J Neurol Sci 1979;6:1-6.
-
(1979)
Can J Neurol Sci
, vol.6
, pp. 1-6
-
-
Broughton, R.1
Mamelak, M.2
-
16
-
-
0021922485
-
The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy
-
Scharf MB, Brown D, Woods M, Brown L, Hirschowitz J. The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy. J Clin Psychiatry 1985;46:222-5. (Pubitemid 15093425)
-
(1985)
Journal of Clinical Psychiatry
, vol.46
, Issue.6
, pp. 222-225
-
-
Scharf, M.B.1
Brown, D.2
Woods, M.3
-
17
-
-
0025058256
-
The effect of gamma-hydroxybutyrate on nocturnal and diurnal sleep of normal subjects: Further considerations on REM sleep-triggering mechanisms
-
Lapierre O, Montplaisir J, Lamarre M, Bedard MA. The effect of gamma-hydroxybutyrate on nocturnal and diurnal sleep of normal subjects: further considerations on REM sleep. Sleep 1990;13:24-30. (Pubitemid 20039775)
-
(1990)
Sleep
, vol.13
, Issue.1
, pp. 24-30
-
-
Lapierre, O.1
Montplaisir, J.2
Lamarre, M.3
Bedard, M.A.4
|